Without prejudice to Article 5, where an application for marketing authorisation is submitted for a medicinal product on which scientific advice has already been given by the Agency, the fee payable to the Agency for the examination of that application shall be due only if a marketing authorisation is granted.
Art. 6 Commission Regulation (EC) No 2049/2005 of 15 December 2005 laying down, pursuant to Reg…
Conditional fee exemption
In forcesince 15 Dec 2005